If you are looking for alternatives for compounded tirzepatide, you have probably decided something already: the service you use now is not the one you want to stay with. Maybe the dose keeps climbing and the progress does not. Maybe a side effect has gone unanswered, or the compounding news finally reached you, or you simply realized that no one in the arrangement has ever looked at your blood. You want to know where to go next, and how to get there without a gap or a misstep.
This piece lays out the alternatives for compounded tirzepatide as kinds of care rather than a list of companies, because the choice that matters is the model, not the logo. We do not review any named company here, including the one in this page's address, and nothing below is a statement about any particular service. GoodLife Health is one of the options, so we have a stake in the answer; we will tell you plainly where another option fits you better.
- Compounded tirzepatide is not FDA-approved, and the shortage that allowed mass compounding was declared resolved in December 2024, with the grace periods closing in February and March 2025.
- The real alternatives are four kinds of care: your own primary care clinician, an obesity medicine specialist, an endocrinologist, or a clinician-led membership.
- Branded tirzepatide is available to self-pay patients at a published price: through LillyDirect, Zepbound vials were $299 to $449 a month depending on dose as of September 2026.
- Whichever you choose, the move works best in a set order: keep your current dose, gather your history, get labs, then let a clinician set the branded dose.
- GoodLife Health prescribes branded medication only, after labs, to the pharmacy you choose, and charges the same $299 a month whatever the dose.
Why people leave compounded tirzepatide services
The reasons tend to arrive together. The first is the dose schedule. Many services raise the dose on a calendar, and the price rises with it, so the plan for a plateau is the next step up. The second is silence: a side effect, a stall, or a question about whether thyroid, insulin or polycystic ovary syndrome is involved, answered with a template or not at all. The third is the product itself.
On that, the record is public. The FDA declared the tirzepatide shortage resolved in December 2024, and the grace periods for compounders closed on February 18, 2025 for 503A pharmacies and on March 19, 2025 for 503B outsourcing facilities, as its page on medications containing semaglutide and tirzepatide records. The FDA also states that compounded drugs are not FDA-approved and that it does not review them for safety, effectiveness or quality before they are sold, and its page on unapproved GLP-1 drugs records adverse event reports including dosing errors.
We do not say compounded tirzepatide is dangerous in itself. We say that the medicine with a label, a fixed dose and the trial evidence behind it is now available to buy directly, and that most people who leave a compounded service are looking for that medicine and for someone who will look at them.
The four alternatives
Your own primary care clinician
If you have a primary care clinician who knows you, start by asking. Some will prescribe Zepbound or Mounjaro and follow you; some will not prescribe GLP-1 medicines for weight at all, and many have little time for the follow-up these medicines need.
Best for: someone with an established, unhurried relationship, a clinician comfortable prescribing and monitoring, and insurance that may cover the medicine.
Watch for: an annual visit model, in which labs are drawn once a year and a plateau waits months for a conversation.
An obesity medicine specialist
Physicians certified by the American Board of Obesity Medicine focus on exactly this problem. A specialist can be the right home when your history is complicated: previous medicines that failed, significant weight-related conditions, or a question about bariatric surgery.
Best for: complex cases and anyone who wants a specialist's depth, in person or by telehealth.
Watch for: waiting lists, insurance rules on specialist visits, and whether follow-up is frequent enough to manage dose changes well.
An endocrinologist
If you have type 2 diabetes, a thyroid disorder, or another hormonal condition alongside weight, an endocrinologist may be the right lead, often with Mounjaro, which is approved for type 2 diabetes.
Best for: established endocrine disease.
Watch for: referral requirements and long waits for a first appointment.
A clinician-led membership
This is where GoodLife Health sits. A flat monthly fee pays for the care: quarterly labs, a clinician who stays, messaging and video visits. The medicine is prescribed separately to the pharmacy you choose, at that pharmacy's own price.
Best for: someone who wants labs every quarter, a clinician who asks why before raising a dose, and a price for care that does not change with the medicine.
Watch for: the fee, which is in addition to the medication, and the fact that a membership does not replace health insurance.
One thing is shared by all four. Branded tirzepatide can be bought directly: through LillyDirect, Zepbound vials were $299 to $449 a month depending on dose as of September 2026, according to Lilly's Zepbound savings page, and any licensed prescriber can send a prescription there. Whether your insurance covers the medicine is between you, your plan and your pharmacy, and prior authorization is the pharmacy's process.
The questions that tell the alternatives apart
Who draws labs, and how often? A plateau is only explainable with data. Ask what is measured and when.
What happens at a plateau? Our clinicians work to a rule our clinical lead puts in one sentence: "I don't automatically increase a GLP-1 every month because the dosing schedule says that another dose exists." Ask any alternative what theirs is.
Who earns when the dose rises? If the price of care climbs with the dose, the incentive is in the schedule.
Will the same clinician be there in six months? Continuity is what turns a prescription into care.
Do not stop compounded tirzepatide abruptly, and do not convert your dose yourself. Units in a compounded vial do not translate reliably into milligrams of a branded medicine; the clinician you move to should set the starting dose from your history and labs.


If insurance might cover the branded medicine
Moving from compounded to branded tirzepatide is also a moment to check whether your insurance will help, because the answer may have changed since you started.
Mounjaro is approved for type 2 diabetes, and plans that cover diabetes medicines often cover it for that diagnosis. Zepbound is approved for chronic weight management, and coverage for weight management varies widely from plan to plan and employer to employer. The only reliable way to know is to ask: call the number on your insurance card, name the medicine, and ask whether it is covered, at what tier, and whether prior authorization is required.
If prior authorization is required, it runs through the pharmacy and your prescriber's office, not through a membership. It is the pharmacy's process; no one can promise its outcome or its speed, and anyone who does is overpromising. If the answer is no, the manufacturer's self-pay price is the fallback, and it is published in advance.
If you have a health savings account or a flexible spending account, check whether your plan treats prescription medication and care fees as eligible expenses. Membership fees for direct care are generally eligible, never always, so confirm with your plan administrator before you count on it.
Whichever alternative you choose, ask the new clinician's team to tell you, before the first prescription, where it will be sent and roughly what it will cost you. A good team will answer that plainly.
How to move without a gap
Keep your current supply until the new clinician has seen you. A gap can bring back appetite and side effects at once, and a guessed restart is how switches go badly.
Gather your history. The product and concentration on the label, your dose in units, the date of each change, the side effects you have had, and any labs drawn since you began. Ask your current service for your records in writing.
Get labs before the first branded prescription. Fasting insulin, A1C, a lipid panel, thyroid function and a metabolic panel give the new clinician a baseline and often explain a plateau.
Close the old account deliberately. Cancel future shipments in writing and keep the confirmation, so nothing arrives with a charge after you have moved.
Where tirzepatide care is going
The compounded tirzepatide market grew out of a shortage that has ended. The manufacturer now sells the branded medicine to self-pay patients at a published price, which means the choice in front of you is no longer between a cheaper copy and an original you could not get. It is between kinds of care. We think the next phase of this treatment is defined by the care around the medicine: the diagnosis before the prescription, the markers followed every quarter, and a clinician who decides with you whether the dose should rise, hold or fall. Each of the four alternatives can offer that. GoodLife Health is built to offer nothing else.
What GoodLife Health costs, buys, and does not
The membership is $299 a month, month to month. $598 is held on your card at sign-up, charged only once you are accepted, and covers the first two months. If a clinician cannot accept you into care, the $598 hold is released and you are never charged; once you are accepted, the first two months are non-refundable. Medication billed by a pharmacy follows that pharmacy's own return and refund policy. The fee is the same whatever the medication and whatever the dose.
It buys four cardiometabolic lab panels a year, including ApoB, Lp(a), fasting insulin, A1C, hs-CRP and thyroid function, with every result in your hands; a clinician who stays; messaging and video visits; and branded medication prescribed when indicated to your pharmacy at its price, with nothing taken on it. It returns the reason your progress changed. It does not replace your health insurance, and it does not guarantee weight loss, coverage of a medication or acceptance into care. If you are on compounded tirzepatide now, bring your history; there is no forced restart.
Who this is not for
If you want to stay on compounded tirzepatide at the lowest possible price, GoodLife Health is not for you; we do not compete with the $99-a-month compounded app and will not prescribe compounded GLP-1. It is also not for someone who wants a prescription without labs, for anyone under 18, pregnant or planning a pregnancy on a GLP-1, for someone who needs urgent or full-scope primary care, or for anyone outside the United States. And if your own primary care clinician will prescribe and follow you closely, that may be the better alternative for you.
The choice in front of you is no longer between a copy and the original; it is between kinds of care.
Frequently Asked Questions
What are the alternatives for compounded tirzepatide?
Four kinds of care: your own primary care clinician, an obesity medicine specialist, an endocrinologist, or a clinician-led membership such as GoodLife Health. Each can prescribe branded tirzepatide, Zepbound or Mounjaro, when it is indicated.
Can I buy branded tirzepatide without insurance?
Yes. Through LillyDirect, Zepbound vials were $299 to $449 a month depending on dose as of September 2026. Any licensed prescriber can send the prescription there.
How do I switch from compounded tirzepatide without a gap?
Keep your current dose until the new clinician has seen you, bring your dose history and label, get labs, and let the clinician set the branded starting dose. Then cancel future shipments in writing.
Does GoodLife Health review or rank other companies?
No. This page compares kinds of care, not named companies, and makes no statement about any particular service.
Related Reading
- Compounded Tirzepatide: What Patients Need to Know
- How GLP-1 Telehealth Companies Make Money: A Plain-Language Whitepaper
- The True Monthly Cost of GLP-1 Telehealth
- How to Choose the Right Health Membership Plan
References
- FDA: Medications Containing Semaglutide and Tirzepatide, Safety Information and Compounding. 2025. www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/medications-containing-semaglutide-marketed-type-2-diabetes-or-weight-loss
- FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (U.S. Food and Drug Administration). 2025. www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
- Zepbound Self Pay Journey Program: LillyDirect vial pricing (Eli Lilly). 2026. zepbound.lilly.com/savings